Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study)

1068-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Safety Profile of a Needle-Free Insulin Injector with Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db19-1068-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1068-P

Author(s):

LIMING CHEN ◽

LINONG JI ◽

YANGANG WANG ◽

ZHONGSHU MA ◽

XINGWU RAN ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Safety Profile ◽

Chinese Patients ◽

Open Label ◽

Parallel Group ◽

1080-P: A Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing Patient Satisfaction and Compliance with a Needle-Free Insulin Injector vs. Conventional Insulin Pen Injections in Chinese Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db19-1080-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1080-P

Author(s):

YANGANG WANG ◽

LINONG JI ◽

LIXIN GUO ◽

XINGWU RAN ◽

LIMING CHEN ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Patient Satisfaction ◽

Chinese Patients ◽

Open Label ◽

Parallel Group ◽

Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial

10.1111/dom.12674 ◽

2016 ◽

Vol 18 (8) ◽

pp. 803-811 ◽

Cited By ~ 14

Author(s):

L. Zang ◽

Y. Liu ◽

J. Geng ◽

Y. Luo ◽

F. Bian ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Chinese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Active Comparator

Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study)

EClinicalMedicine ◽

10.1016/j.eclinm.2020.100368 ◽

2020 ◽

Vol 23 ◽

pp. 100368

Author(s):

Linong Ji ◽

Leili Gao ◽

Liming Chen ◽

Yangang Wang ◽

Zhongshu Ma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Insulin Delivery ◽

Chinese Patients ◽

Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial

International Journal of Clinical Practice ◽

10.1111/ijcp.12987 ◽

2017 ◽

Vol 71 (9) ◽

pp. e12987 ◽

Cited By ~ 1

Author(s):

You-Cheol Hwang ◽

Kun-Ho Yoon ◽

Bong-Soo Cha ◽

Kwan-Woo Lee ◽

Hak Chul Jang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Calcium Channel ◽

Calcium Channel Blockers ◽

Channel Blockers ◽

Open Label ◽

Parallel Group

Insulin Delivery with a Needle-Free Insulin Injector Versus a Conventional Insulin Pen in Chinese Patients with Type 2 Diabetes Mellitus: A 16-Week, Multicenter, Randomized Clinical Trial (the FREE Study)

SSRN Electronic Journal ◽

10.2139/ssrn.3537090 ◽

2020 ◽

Author(s):

Linong Ji ◽

Leili Gao ◽

Liming Chen ◽

Yangang Wang ◽

Zhongshu Ma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Insulin Delivery ◽

Chinese Patients ◽

Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination ( iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26‐week, open‐label, multicentre study: The LixiLan JP‐O2 randomized clinical trial

10.1111/dom.14036 ◽

2020 ◽

Vol 22 (S4) ◽

pp. 14-23 ◽

Cited By ~ 1

Author(s):

Yasuo Terauchi ◽

Takahiro Nakama ◽

Robert Spranger ◽

Atsushi Amano ◽

Takahiro Inoue ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study)

10.1111/dom.12942 ◽

2017 ◽

Vol 19 (11) ◽

pp. 1513-1520 ◽

Cited By ~ 9

Author(s):

Jin Du ◽

Li Liang ◽

Hui Fang ◽

Fengmei Xu ◽

Wei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Chinese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Smart Study ◽

Metformin Monotherapy

Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP‐L randomized clinical trial

10.1111/dom.14005 ◽

2020 ◽

Vol 22 (S4) ◽

pp. 3-13 ◽

Cited By ~ 3

Author(s):

Hideaki Kaneto ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Daisuke Watanabe ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Decision letter for "Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicenter study: The L"

10.1111/dom.14036/v3/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Open Label ◽

Oral Antidiabetic